# A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression

> **NCT01524497** · PHASE2,PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 382 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Trazodone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01524497
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-08
- **Final completion:** 2013-11
- **Target enrollment:** 382 (ACTUAL)
- **Last updated:** 2014-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524497, "A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01524497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*